... Staging of small cell and non- smallcelllung cancer. University of Iowa Virtual Hos-pital; 1999. 6. Hopwood P, Stephens RJ: Symptoms at presentation for treat-ment in patients with lung cancer: ... Treatment of Cancer Quality-of-Life Questionnaire -Lung Cancer- 17items; EQ-5D: EuroQoL-5 Dimensions; HRQL: Health-related Quality of Life; NSCLC: Non- SmallCellLung Can-cer; SF-36: Short-Form ... stateutilities for metastatic breast cancer. Br J Cancer 2006,95(6):683-90.17. Cancer Research UK [http://www.cancerresearchuk.org]18. Cancer Help [http://www.cancerhelp.org.uk]19. Association for...
... of non- small- cell lung cancer. Int J Radiat Oncol Biol Phys 2002, 52:382-389.16. Qiao X, Tullgren O, Lax I, Sirzén F, Lewensohn R: The role of radiotherapyin treatment of stage I non- smallcell ... early- stage non- small- celllung cancer: clinical implications. Radiother Oncol2010, 94:1-11.27. Chen Y, Guo W, Lu Y, Zou B: Dose-individualized stereotactic bodyradiotherapy for T1-3N0 non- small ... Bosch W, Lockett MA, Perez CA:Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non- smallcelllungcancer (NSCLC). Int J Radiat Oncol BiolPhys 1999, 45:323-329.25....
... surgery in patients withoperable lung cancer. A randomized phase III trial of Radiosurgery Or Surgery for operable Early stage (stage 1A) non- smallcell Lung cancer (ROSEL, ClinicalTrials.gov ... body radiotherapy forstage I non- smallcelllung cancer. Radiother Oncol 2007, 85:429-434.39. Sinha B, McGarry RC: Stereotactic body radiotherapy for bilat-eral primary lung cancers: the Indiana ... Lagerwaard FJ:Critical review of nonsurgical treatment options forstage I non- smallcelllung cancer. Oncologist 2008, 13:309-319.41. Brock J, Ashley S, Bedford J, Nioutsikou E, Partridge M,...
... as lung cancer. It is more convenient for the patients and reduces health care costs.This study reports our results on patients with medically inoperable, early stage, non- smallcell lung cancer ... not for citation purposes)Radiation OncologyOpen AccessResearchAbsence of toxicity with hypofractionated 3-dimensional radiation therapy for inoperable, early stage non- smallcelllung cancer Sergio ... 6(page number not for citation purposes)BackgroundThe use of accelerated hypofractionated radiation therapyis an attractive option for patients with early stage non- small celllungcancer (NSCLC)...
... Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001, 94:153-156.2. Non- smallCellLungCancer Collaborative Group: Chemotherapyin nonsmallcelllung cancer: a meta-analysis ... cisplatin-teniposide in patients withadvanced non- small- celllung cancer. The European Organi-zation for Research and Treatment of CancerLung Cancer Cooperative Group. J Clin Oncol 1998, 16:2133-2141.7. ... paclitaxel plus gemcitabine in advanced non- small- cell lung cancer: a phase III trial of the European Organiza-tion for Research and Treatment of CancerLung Cancer Group – EORTC 08975. J Clin Oncol...
... Non- small- celllungcancer harbouring mutations in the EGFRkinase domain. Clin Transl Oncol 2010, 12:75-80.9. Gazdar AF: Activating and resistance mutations of EGFR in non- small- cell lung cancer: ... lungcancer patients.Methods: EGFR mutation status was analyzed by DNA assays, and compared with IHC results in five non- small- cell lungcancer (NSCLC) cell lines and tumor samples from 78 stage ... antibodies for the detection ofEGFR mutations in non- small- celllung cancer. Clin Cancer Res 2009,15:3023-3028.13. Motoi N, Szoke J, Riely GJ, Seshan VE, Kris MG, Rusch VW, Gerald WL,Travis WD: Lung...
... iotherapy, Oligometastases, Non- SmallCellLung Cancer Background Non- smallcelllungcancer (NSCLC) is the leadingcause of cancer mortality in the United States [1].Patients with stage IV NSCLC typically ... of 7 RESEARC H Open AccessComparison of outcomes in patients with stage IIIversus limited stage IV non- smallcelllung cancer Praveena Cheruvu1, Su K Metcalfe1, Justin Metcalfe1, Yuhchyau ... Paul Okunieff2and Michael T Milano1*AbstractBackground: Standard therapy for metastatic nonsmallcelllungcancer (NSCLC) includes palliative systemicchemotherapy and/or radiotherapy....
... AbstractBackground: To evaluate the performance of surface-based deformable image registration (DR) for adaptive radiotherapy of non- smallcelllungcancer (NSCLC).Methods: Based on 13 patients ... megavoltage CT imaging during exter-nal beam radiotherapy for non- small- celllung cancer: obser-vations on tumor regression during treatment. Int J RadiatOncol Biol Phys 2005, 63:1024-1028.10. ... of deformable image registrationComparison of CTplan and CTdeform was performed for evaluation of the DR. Based on ROIextended, DR improvedthe CC for images acquired mid-way of the treatment course...
... irradiation for medically inoperable patients with peripheral stage I non- smallcelllung cancer. LungCancer 1999, 26:137-142.23. Slotman BJ, Antonisse IE, Njo KH: Limited field irradiation inearly stage ... 1 of 9(page number not for citation purposes)Radiation OncologyOpen AccessResearchStereotactic, single-dose irradiation of stage I non- smallcelllung cancer and lung metastasesPeter Fritz*1, ... radiotherapy for stage I non- smallcelllungcancer using a novel irradiationtechnique: patient self-controlled breath-hold and beamswitching using a combination of linear accelerator and CTscanner. Lung...
... marker expression in tumor cells versus stromal cells in non smallcelllung cancer. Clin Cancer Res 2007, 13:6649-57.24. World Health Organization: Histological Typing of Lung and PleuralTumours. ... Paclitaxel-carboplatin alone or withbevacizumab for non- small- celllung cancer. N Engl J Med 2006,355:2542-50.21. Besse B, Ropert S, Soria JC: Targeted therapies in lung cancer. Ann Oncol2007, 18(Suppl 9):ix135-ix142.22. ... in non- smallcelllung cancer. Clin Cancer Res 2008, 14:5220-7.30. Andersen S, Eilertsen M, Donnem T, et al: Diverging prognostic impacts ofhypoxic markers according to NSCLC histology. Lung Cancer...
... non- smallcelllungcancer cell lines. Mol Cancer Res. 2006; 4(8): 521-8. 102. Taguchi F, Solomon B, Gregorc V, et al. Mass spectrometry to classify non- small- celllungcancer patients for ... death world-wide (1). Lungcancer is generally classified into two histological types, smallcelllungcancer (SCLC) and non smallcelllungcancer (NSCLC). NSCLC accounts for approximately 85% ... advanced non- small- celllung cancer. Results of a meta-analysis of the literature. Chest. 1994; 106(3): 861-5. 8. Grilli R, Oxman AD, Julian JA. Chemotherapy for advanced non- small- celllung cancer: ...
... Napoli1, Giacomo Carteni’1AbstractBackground: Defining the optimal treatmentfor patients with inoperable nonsmallcelllungcancer (NSCLC),presenting with metastatic mediastinal lymph nodes, ... after the first few cycles should notautomatically discourage to continue treatment. IntroductionIn non- smallcelllungcancer (NSCLC), mediastinallymphnode involvement comprises a wide spectrum ... induced byfirst-line chemotherapy with single agentdocetaxel in a patient with advanced non small celllung cancer Ferdinando Riccardi1*, Giuseppe Di Lorenzo1, Carlo Buonerba1, Guglielmo Monaco2,...
... JD, Komaki R, Mohan R: Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced -stage non- small- celllung cancer. Int J Radiat Oncol Biol Phys 2004, 58:1258-1267.21. ... W, Lockett MA, Perez CA: Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non- smallcelllungcancer (NSCLC). Int J Radiat Oncol Biol Phys 1999, 45:323-329.15. ... method for the management of unresectable locally advanced non- small celllungcancer (NSCLC). Unfortunately, the longersurvival is achieved at the price of greater toxicity of the lung and...
... energy agency (IAEA)consultants' meeting on elective nodal irradiation in lung cancer: non- smallcelllungcancer (NSCLC). Int J Radiat OncolBiol Phys 2008, 72(2):335-342.6. Therasse P, ... response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Insti-tute of the United States, National Cancer Institute of Can-ada. J Natl Cancer ... Sahijdak WM, Hayman JA: Incidental dose to clinicallynegative nodes from conformal treatment fields for nons-mall celllung cancer. Int J Radiat Oncol Biol Phys 1999, 45:S244.13. Klopp AH, Chang...